PET biodistribution study of subcutaneous and intravenous administration of adalimumab in an inflammatory bowel disease model

J Codesido, L García-Varela, X García-Otero… - International Journal of …, 2025 - Elsevier
Monoclonal antibodies targeting tumor necrosis factor-alpha (antiTNF-α) are used for
patients with immuno-mediated illness as inflammatory bowel disease (IBD). However, 20 …